, Volume 177, Issue 1–2, pp 178–184 | Cite as

Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5′ nuclease assay

  • Guanshan Zhu
  • Robert H. Lipsky
  • Ke Xu
  • Sameer Ali
  • Thomas Hyde
  • Joel Kleinman
  • Longina A. Akhtar
  • Deborah C. Mash
  • David GoldmanEmail author
Original Investigation



A common polymorphism, Val158Met, alters catechol-O-methyltransferase (COMT) enzyme activity and has been linked to psychiatric phenotypes. Bray et al. (2003) reported that COMT is subject to differential allele expression in brain, finding modest (13–22%) underexpression of a haplotype containing Val158. However, disparate findings by another group who used the same method, but in lymphoblasts, raise the issues of tissue specificity, magnitude of differential expression, and identity of loci altering expression.


We measured COMT allele expression ratios in heterozygous human lymphoblast cell lines and brains.


Using transcribed single nucleotide polymorphisms as endogenous reporters, we developed an RT-coupled 5′ nuclease assay for allele expression ratios and applied it to 63 COMT rs4818(C>G) heterozygotes and 68 Val158Met [rs4680(G>A)] heterozygotes.


For rs4818(C>G), the C allele was overexpressed relative to the G allele in 18 of 27 lymphoblast lines and 23 of 36 brains. For Val158Met, Met158 was overexpressed relative to Val158 in all (29 of 29) lymphoblast lines and all (39 of 39) brains. Each of the 22 rs4818 heterozygotes without differential allele expression was a Val158/Val158 homozygote. The Met158 allele was overexpressed by 65–77% when compared with Val158 in lymphoblasts and brain. Haplotype augmented ability to predict expression in brain only. However, the expression of the Val158 allele on the high-expressing haplotype was only 19% higher than Val158 alleles on the other haplotype background.


COMT alleles are differentially expressed. The Met158 allele predicts higher mRNA expression in both brain and lymphoblasts. As exemplified here, the RT-coupled 5′ nuclease assay is a reliable method for the quantitative evaluation of cis-acting regulatory effects.


COMT Allele-specific expression Single nucleotide polymorphism Haplotype Lymphoblast Brain Human 



We thank Margaret J. Basile for organizing brain samples.


  1. Axelrod J, Tomchick R (1958) Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 233:702–705PubMedGoogle Scholar
  2. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X, Goldman RS et al (2002) Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52:701–707CrossRefPubMedGoogle Scholar
  3. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O’Donowan MC (2003) A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152–161CrossRefPubMedGoogle Scholar
  4. DeMille MMC, Kidd JR, Ruggeri V, Palmatier MA, Goldman D, Odunsi A, Okonofua F et al (2002) Population variation in linkage disequilibrium across the COMT gene considering promoter region and coding region variation. Hum Genet 111:521–537CrossRefPubMedGoogle Scholar
  5. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D et al (2001) Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917–6922CrossRefPubMedGoogle Scholar
  6. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003) Genetic origins of anxiety in women; a role for a functional COMT polymorphism. Psychiatr Genet 13:33–41CrossRefPubMedGoogle Scholar
  7. Higuchi R, Watson RM (1999) Kinetic PCR analysis using a CCD-camera and without using oligonucleotide probes. In: Innis MA, Gelfand DH, Sninsky JJ (eds) PCR applications: protocols for functional genomics. Academic, San Diego, pp 263–284Google Scholar
  8. Jiang H, Ho SL, Xie T, Young LP (1998) Distribution of catechol-O-methyltransferase expression in human central nervous system. Neurochemistry 9:2861–2864Google Scholar
  9. Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, Ott J, Gogos JA (1997) Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94:4572–4575CrossRefPubMedGoogle Scholar
  10. Knight JC, Keating BJ, Rockett KA, Kwiatkowski DP (2003) In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nat Genet 33:469–475CrossRefPubMedGoogle Scholar
  11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996) Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243–250PubMedGoogle Scholar
  12. Lee LG, Connell CR, Bloch W (1993) Allelic discrimination by nick translation PCR with fluorogenic probes. Nucleic Acids Res 21:3761–3766PubMedGoogle Scholar
  13. Lo HS, Wang Z, Hu Y, Yang HH, Gere S, Buetow KH, Lee MP (2003) Allelic variation in gene expression is common in the human genome. Genome Res 13:1855–1862CrossRefPubMedGoogle Scholar
  14. Long JC (1999) Multiple Locus Haplotype Analysis, version 2.0. Software and documentation distributed by the author. Section on Population Genetics and Linkage, Laboratory of Neurogenetics, NIAAA, National Institutes of Health, Bethesda, MDGoogle Scholar
  15. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I, Taskinen J (1995) Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202–4210PubMedGoogle Scholar
  16. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D (2002) A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 159:652–654CrossRefPubMedGoogle Scholar
  17. Mansfield ES (1993) Diagnosis of down syndrome and other aneuploidies using quantitative polymerase chain reaction and small tandem repeat polymorphisms. Hum Mol Genet 2:43–50PubMedGoogle Scholar
  18. Matsumoto M, Weickert CS, Akil M, Lipska BK, Hyde TM, Herman MM, Kleinman JE et al (2003) Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function. Neuroscience 116:127–137CrossRefPubMedGoogle Scholar
  19. Ohlsson R, Hall K, Ritzen M (1995) Parental Imprinting: causes and consequences. Cambridge University, CambridgeGoogle Scholar
  20. Palmatier MA, Kang AM, Kidd KK (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46:557–567CrossRefPubMedGoogle Scholar
  21. Price SJ, Greaves DR, Watkins H (2001) Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J Biol Chem 276:7549–7558CrossRefPubMedGoogle Scholar
  22. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, Reznik I et al (2002) A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296–1302CrossRefPubMedGoogle Scholar
  23. Spielman RS, Weinshilboum RM (1981) Genetics of red cell COMT activity: analysis of thermal stability and family data. Am J Med Genet 10:279–290PubMedGoogle Scholar
  24. Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169CrossRefPubMedGoogle Scholar
  25. Tenhunen J, Salminen M, Lundström K, Tiviluoto T, Savolainen R, Ulmanen I (1994) Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223:1049–1059PubMedGoogle Scholar
  26. Uejima H, Lee MP, Cui H, Feinberg AP (2000) Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios. Nat Genet 25:375–376CrossRefPubMedGoogle Scholar
  27. Venter CJ, Adams MD, Myers EW, Li PW, Mrual RJ, Sutton GG et al (2001) The sequence of the human genome. Science 291:1304–1351CrossRefPubMedGoogle Scholar
  28. Weinshilboum RM, Raymond FA (1977) Inheritance of low erythrocyte catechol-O-methyltransferase activity in man. Am J Hum Genet 29:216–218Google Scholar
  29. Xu K, Lipsky RH, Mangal W, Ferro E, Goldman D (2002) Single-nucleotide polymorphism allele frequencies determined by quantitative kinetic assay of pooled DNA. Clin Chem 48:1605–1608PubMedGoogle Scholar
  30. Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW (2002) Allelic variation in human gene expression. Science 297:1143CrossRefPubMedGoogle Scholar
  31. Zhu G, Lipsky RH, Xu K, Ali S, Hyde H, Kleinman J, Akhtar LK et al (2002) RT-coupled 5′ nuclease assay—a general and high throughput method for detection of gene differential allele expression using transcribed SNPs as endogenous reporters. Am J Hum Genet 71[Suppl 4]:401Google Scholar
  32. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240–1243CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Guanshan Zhu
    • 1
    • 2
  • Robert H. Lipsky
    • 1
  • Ke Xu
    • 1
  • Sameer Ali
    • 1
  • Thomas Hyde
    • 3
  • Joel Kleinman
    • 3
  • Longina A. Akhtar
    • 1
  • Deborah C. Mash
    • 4
  • David Goldman
    • 1
    Email author
  1. 1.Laboratory of Neurogenetics, National Institute on Alcohol Abuse and AlcoholismNational Institutes of HealthRockvilleUSA
  2. 2.Changhai HospitalShanghaiPeople’s Republic of China
  3. 3.Clinical Brain Disorders BranchNIMHBethesdaUSA
  4. 4.Department of NeurologyUniversity of MiamiMiamiUSA

Personalised recommendations